all report title image

Animal Vaccines Market, By Product Type (Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, Recombinant Vaccines), By Application (Companion Animal, Livestock Animal, Poultry, Aquaculture), By Distribution Channel (Veterinary Clinics, Veterinary Hospitals, Veterinary Research Institutes, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : Mar 2026
  • Code : CMI4989
  • Pages :151
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical
Ingographics Image

Animal vaccines are parenteral products that are used as prophylactic as well as in the treatment of various veterinary diseases. Animal vaccines play a crucial role in ensuring good health, longevity, and improving overall productivity of pets and livestock, in a cost-effective manner. Companion animal vaccines reduce transmission of various diseases from animals to humans. These vaccines are parenteral products that are used in prophylactic treatment of various diseases such as blastomycosis, psittacosis cat scratch disease, and others.

Market Dynamics

Vaccines are preventive medicines for the treatment of various diseases. Some of the vaccines are expensive to afford. So various companies operating in the global animal vaccines market offer reimbursement to reduce the expenses of pet vaccinations which is expected to augment the market growth over the forecast period. For instance, For canine patients receiving an ULTRA Duramune DAP combination and Bronchi-Shield ORAL, Elanco reimburses normal and customary charges (up to US$ 5,000) associated with the diagnosis and treatment of any patient suffering respiratory disease due to canine parainfluenza virus infection Moreover, Elanco reimburses standard and reasonable diagnostics (a biopsy and histopathological exam) to reach a definitive diagnosis. With a confirmed diagnosis, Elanco reimburses standard and reasonable treatment costs up to US$ 1,500. For canine patients receiving an ULTRA Duramune DAP combination and Bronchi-Shield ORAL, Elanco reimburses normal and customary charges (up to US$ 5,000) associated with the diagnosis and treatment of any patient suffering respiratory disease due to canine parainfluenza virus infection.

Moreover, various pet health insurance companies provide coverage for vaccines, examinations, teeth cleaning, spaying, and other pet health related activities. Some of the pet health insurance companies include ASPCA Pet Insurance, PetFirst Insurance, Embrace Pet Insurance Agency, and PetPlan, Allstate Insurance Company, among others.

Key features of the study

  • This report provides an in-depth analysis of the global animal vaccines market, market size (US$ Mn), and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global animal vaccines market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, strategies.
  • Key companies covered as a part of this study include Merck & Co., Inc., Boehringer Ingelheim International GmbH., Zoetis Inc., Elanco Animal Health Incorporated, Ceva, HIPRA, Romvac Company Sa, Biovac, Vaxxinova International BV, and Biogénesis Bagó
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global animal vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global animal vaccines market

Market Segmentation

  • By Product Type
    • Attenuated Live Vaccines
    • Conjugate Vaccines
    • Inactivated Vaccines
    • Subunit Vaccines
    • Toxoid Vaccines
    • DNA Vaccines
    • Recombinant Vaccines
  • By Application
    • Companion Animal
    • Livestock Animal
    • Poultry
    • Aquaculture
  • By Distribution Channel
    • Veterinary Clinics
    • Veterinary Hospitals
    • Veterinary Research Institutes
    • Others 
  • By Region
    • North America
      • U.S.
      • Canada
    • Latin America
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
    • Europe
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East & Africa
      • GCC Countries
      • Israel
      • Rest of Middle East & Africa
  • Key Players
    • Merck & Co., Inc.
    • Boehringer Ingelheim International GmbH.
    • Zoetis Inc.
    • Elanco Animal Health Incorporated
    • Ceva
    • HIPRA
    • Romvac Company Sa
    • Biovac
    • Vaxxinova International BV
    • Biogenesis Bago

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Product Type
      • Market Snapshot, By Application
      • Market Snapshot, By Distribution Channel
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Drivers and Restraints
    • Opportunities
    • Impact Analysis
    • Key developments
    • New Product Launches
    • Partnerships and Agreements
    • Technological Landscape
    • Brand Analysis
    • Regulatory Scenario
    • Epidemiology
    • Reimbursement Schemes
    • PORTER Analysis
  4. Global Animal Vaccines Market, By Product Type, 2026 – 2032, (USD Mn)
    •  Introduction
      • Market Share Analysis, 2021 and 2032 (%)
      • Y-o-Y Growth Analysis, 2026 – 2032
      • Segment Trends
    • Attenuated Live Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2026 – 2032, (USD Mn)
    • Conjugate Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2026 – 2032, (USD Mn)
    • Inactivated Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2026 – 2032, (USD Mn)
    • Subunit Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2026 – 2032, (USD Mn)
    • Toxoid Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2026 – 2032, (USD Mn)
    • DNA Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2026 – 2032, (USD Mn)
    • Recombinant Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2026 – 2032, (USD Mn)
  5. Global Animal Vaccines Market, By Application, 2026 – 2032, (USD Mn)
    • Introduction
      • Market Share Analysis, 2021 and 2032 (%)
      • Y-o-Y Growth Analysis, 2026 – 2032
      • Segment Trends
    • Companion Animal
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2026 – 2032, (USD Mn)
    • Livestock Animal
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2026 – 2032, (USD Mn)
    • Poultry
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2026 – 2032, (USD Mn)
    • Aquaculture
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2026 – 2032, (USD Mn)
  6. Global Animal Vaccines Market, By Distribution Channel, 2026 – 2032, (USD Mn)
    • Introduction
      • Market Share Analysis, 2021 and 2032 (%)
      • Y-o-Y Growth Analysis, 2026 – 2032
      • Segment Trends
    • Veterinary Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2026 – 2032, (USD Million)
    • Veterinary Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2026 – 2032, (USD Million)
    • Veterinary Research Institutes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2026 – 2032, (USD Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2026 – 2032, (USD Million)
  7. Global Animal Vaccines Market, By Region, 2026 – 2032, (USD Mn)
    • Introduction
      • Market Share Analysis, By Region, 2021 and 2032 (%)
      • Y-o-Y Growth Analysis, For Regions, 2026–2032
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 – 2032, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 – 2032, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 – 2032, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country 2026 – 2032, (USD Mn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 – 2032, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 – 2032, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 – 2032, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2032, (USD Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 – 2032, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 – 2032, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 – 2032, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2032, (USD Mn)
        • U.K.
        • Germany
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 – 2032, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 – 2032, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 – 2032, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2032, (USD Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 – 2032, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 – 2032, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 – 2032, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2032, (USD Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 – 2032, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 – 2032, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 – 2032, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 – 2032, (USD Mn)
        • North Africa
        • Central Africa
        • South Africa
  8. Competitive Landscape
    • Company Profiles
      • Merck & Co., Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Boehringer Ingelheim International GmbH
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Zoetis Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Elanco Animal Health Incorporated
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Ceva
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • HIPRA
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Romvac Company Sa
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Strategies
      • Biovac
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Strategies
      • Vaxxinova International BV
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Strategies
      • Biogenesis Bago
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Strategies
  9. Section
    • Research Methodology
    • About Us
  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered

860519526

Clutch
Credibility and Certification
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.